Introduction  The oncology landscape is undergoing a remarkable transformation. Advances in precision medicine, immunotherapy, cell and gene therapies, antibody-drug conjugates (ADCs), and targeted therapies are redefining how cancer is diagnosed, treated, and monitored. These emerging oncology modalities are enabling more personalized treatment approaches, improving patient outcomes, and accelerating the development of innovative therapeutics.  Behind these […]

Most articles on choosing a CRO partner tell you the same thing. Look for experience. Check regulatory expertise. Ask about quality systems. This advice is not necessarily wrong, but it is not very useful either. Almost every CRO company will claim to tick these boxes on their website.  The real problem is different. Sponsors usually know what to look for. What they don’t have […]

Most biotechs write their protocol first. Then they bring in a CRO to help with submissions and operations. It feels like the natural order. Design the science, then handle the paperwork.  This order is usually a mistake. By the time a CRO gets involved, the big decisions are already locked in. Endpoints are chosen. The dose escalation […]

If your pharma company is planning its first trial, or bringing in a new team to run one, you have probably heard people throw around terms like “Phase II” or “Phase III” in meetings. It can feel like everyone else already knows what this mean, and you are the only one guessing.  In this blog, we have broken down clinical […]

Managing a clinical trial means balancing timelines, teams, budgets, data quality, and regulatory requirements at the same time. Effective clinical trial project management brings these moving parts together, helping study teams identify risks early, maintain compliance, and keep trials progressing smoothly from start-up through close-out. Why It Matters and How to Keep Teams, Timelines, and […]

Getting a new drug, biologic, or medical device to market is not a quick process. One of the biggest questions sponsors ask is simple: how long will this take? The answer depends on many factors, but understanding the key milestones can help you plan better and avoid surprises.  In this blog, we have broken down what happens […]

Digital biomarkers are emerging as one of the most promising innovations in clinical research, offering a smarter and more objective way to monitor patient health. Unlike traditional biomarkers that rely on laboratory tests or occasional clinical assessments, digital biomarkers are generated through data collected by wearable devices, smartphones, mobile applications, and connected sensors. These technologies continuously capture health-related information such […]

Rare disease drug development runs on thin margins. Patient populations are small. Since patient populations are limited, high-quality biospecimen collection services become critical for generating reliable clinical evidence. Trial data is limited. Every page of every submission has to work harder to make the case for approval. This is where medical writing services play a role that goes far beyond simply putting […]

India’s pharmaceutical industry is one of the largest in the world by volume. It supplies generic medicines, vaccines, and active pharmaceutical ingredients to more than 200 countries. Behind this growth story, a lesser known but very important player has been at work: the clinical research organisation in India.  These organisations help pharma and biotech companies test new drugs, manage clinical […]

Clinical trials generate large amounts of data. However, collecting data is only one part of the process. The real value comes from analysing that data correctly and drawing reliable conclusions from it.  This is where clinical biostatistics services play an important role.  Biostatisticians help research teams plan the right analytical approach, reduce bias, check data quality, and apply suitable statistical methods. […]